Current Report Filing (8-k)
19 Dezember 2022 - 10:42PM
Edgar (US Regulatory)
false 0000860730 --12-31 0000860730 2022-12-19 2022-12-19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 19, 2022
HCA HEALTHCARE, INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
| Delaware |
|
001-11239 |
|
27-3865930 |
| (State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
| One Park Plaza, Nashville, Tennessee |
|
37203 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
(615) 344-9551
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
| Title of each Class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $.01 par value per share |
|
HCA |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.03. |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On December 19, 2022, the Board of Directors (the “Board”) of HCA Healthcare, Inc. (the “Company”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, adopted an amendment and restatement of the Company’s Second Amended and Restated Bylaws (as so amended, the “Third Amended Bylaws”), which became effective immediately upon adoption by the Board. The amendments (a) revise Article II, Section 11 with respect to the notification and other requirements related to nominations of directors and solicitations of proxies, including requiring compliance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and (b) incorporate technical, ministerial, clarifying and conforming changes related to recent amendments in the Delaware General Corporation Law.
The foregoing description of the Third Amended Bylaws does not purport to be complete and is qualified in its entirety by reference to the Third Amended Bylaws, which are attached to this Current Report on Form 8-K as Exhibit 3.1 and incorporated herein by reference.
| Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
| Date: December 19, 2022 |
|
|
|
HCA HEALTHCARE, INC. |
|
|
|
|
|
|
|
|
|
|
/s/ John M. Franck II |
|
|
|
|
|
|
John M. Franck II Vice President – Legal and Corporate Secretary |
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
